The World Congress of the TERMIS society has taken place in Kyoto, Japan on September 4-7. EBERS has participated as exhibitor in the commercial exhibition of the conference and has successfully introduced its new NORMOPERF technology to renowned researchers and clinical doctors in the transplantation and tissue engineering field. Furthermore, Dr. Pedro Moreo, CEO of EBERS, has held meeting with several local companies with the goal of exploring further commercial agreements in the Japanese market.